retrovir

Generic: zidovudine

Labeler: viiv healthcare company
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name retrovir
Generic Name zidovudine
Labeler viiv healthcare company
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

zidovudine 10 mg/mL

Manufacturer
ViiV Healthcare Company

Identifiers & Regulatory

Product NDC 49702-212
Product ID 49702-212_01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA019910
Listing Expiration 2026-12-31
Marketing Start 2010-10-28

Pharmacologic Class

Established (EPC)
human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
nucleoside reverse transcriptase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49702212
Hyphenated Format 49702-212

Supplemental Identifiers

RxCUI
108396 198352 201907 204534 755298 756209
UPC
0349702211209
UNII
4B9XT59T7S
NUI
N0000175462 N0000009947

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name retrovir (source: ndc)
Generic Name zidovudine (source: ndc)
Application Number NDA019910 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 240 mL in 1 BOTTLE (49702-212-48)
source: ndc

Packages (1)

49702-212-48 240 mL in 1 BOTTLE (49702-212-48)

Ingredients (1)

zidovudine (10 mg/mL)

Linked Drug Pages (1)

RETROVIR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a", "openfda": {"nui": ["N0000175462", "N0000009947"], "upc": ["0349702211209"], "unii": ["4B9XT59T7S"], "rxcui": ["108396", "198352", "201907", "204534", "755298", "756209"], "spl_set_id": ["6df09f15-b102-431c-adde-d7aeef6f5d84"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "240 mL in 1 BOTTLE (49702-212-48)", "package_ndc": "49702-212-48", "marketing_start_date": "20101028"}], "brand_name": "RETROVIR", "product_id": "49702-212_01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a", "dosage_form": "SOLUTION", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "49702-212", "generic_name": "zidovudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RETROVIR", "active_ingredients": [{"name": "ZIDOVUDINE", "strength": "10 mg/mL"}], "application_number": "NDA019910", "marketing_category": "NDA", "marketing_start_date": "20101028", "listing_expiration_date": "20261231"}